AcquisitionOther
Renovaro Biosciences acquired BioSymetrics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Renovaro Biosciences -> BioSymetrics
To enhance biomarker discovery capabilities and accelerate translational research in oncology and precision medicine.
Open source record (SEC) ↗